Deerfield Management Company — 2016 Investments
1 investments dated 2016 · listed companies and verified rows first · show all
Aprecia PharmaceuticalsJan 2016SEC filingmedium confidence
BiotechLanghorne, US
Donald Wetherhold(Executive Officer)Michael Rohlfs(Executive Officer)David Furniss(Executive Officer)Robert Williford(Executive Officer)
BoardLawrence Glassmann(Director)James Evans(Director)
Board seatJonathan Leff· per SEC Form D · $84M raise · filed Jan 2016
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.